Tirzepatide is a novel peptide compound that acts as a triple agonist of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This unique mechanism makes tirzepatide for sale particularly valuable for metabolic research applications.
Our pharmaceutical grade tirzepatide demonstrates exceptional purity and stability, making it ideal for research into obesity and diabetes mechanisms. The compound has shown significant potential in preclinical studies for weight management and glucose control applications.
Key research applications include:
1. Metabolic disorder mechanism studies
2. Obesity-related pathway research
3. Glucose metabolism investigations
4. Energy expenditure measurements
5. Comparative efficacy studies with other GLP-1 analogs
For optimal stability, tirzepatide should be stored frozen at -20°C or below in its lyophilized form. Proper handling procedures should be followed for all research applications.